Search research articles
Contact Us
Filters
Showing results (21-30 of 176) with videos related to
Page
of 18
Sort By:
Pharmacoepidemiology and Drug Safety
|
May 4, 2012
Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect
Carlos O Weiss, Jodi B Segal, Ravi Varadhan
Blood Advances
|
March 24, 2026
Donor type outcomes in setting of PTCy: more apparent than real?
Joseph A Pidala, Ravi Varadhan, Richard J Jones
Annals of Internal Medicine
|
October 19, 2011
The potential for increasing quality and reducing costs
Ravi Varadhan, Carlos O Weiss, Cynthia M Boyd
Statistics in Medicine
|
June 22, 2013
Assessing heterogeneity of treatment effect in a clinical trial with the proportional interactions model
Stephanie A Kovalchik, Ravi Varadhan, Carlos O Weiss
Journal of Clinical Epidemiology
|
April 15, 2018
Considerations when assessing heterogeneity of treatment effect in patient-centered outcomes research
Catherine R Lesko, Nicholas C Henderson, Ravi Varadhan
Mechanisms of Ageing and Development
|
October 28, 2008
Opinion section on frailty
Linda P Fried, Ravi Varadhan, Vilhelm A Bohr
Lifetime Data Analysis
|
April 15, 2014
Semicompeting risks in aging research: methods, issues and needs
Ravi Varadhan, Qian-Li Xue, Karen Bandeen-Roche
Age and Ageing
|
January 15, 2016
Race and fall risk: data from the National Health and Aging Trends Study (NHATS)
Daniel Q Sun, Jin Huang, Ravi Varadhan, et al.
Journal of the American Medical Directors Association
|
June 19, 2021
Geographic Regions Enriched with Frail Older Adults
Jodi B Segal, Jin Huang, Jiafeng Zhu, et al.
American Journal of Epidemiology
|
September 24, 2017
External validation of the claims-based frailty index in the national health and aging trends study cohort
Jodi B Segal, Jin Huang, David L Roth, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 176) with videos related to
Sort By:
Page
of 18
Pharmacoepidemiology and Drug Safety
|
May 4, 2012
Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect
Carlos O Weiss, Jodi B Segal, Ravi Varadhan
Blood Advances
|
March 24, 2026
Donor type outcomes in setting of PTCy: more apparent than real?
Joseph A Pidala, Ravi Varadhan, Richard J Jones
Annals of Internal Medicine
|
October 19, 2011
The potential for increasing quality and reducing costs
Ravi Varadhan, Carlos O Weiss, Cynthia M Boyd
Statistics in Medicine
|
June 22, 2013
Assessing heterogeneity of treatment effect in a clinical trial with the proportional interactions model
Stephanie A Kovalchik, Ravi Varadhan, Carlos O Weiss
Journal of Clinical Epidemiology
|
April 15, 2018
Considerations when assessing heterogeneity of treatment effect in patient-centered outcomes research
Catherine R Lesko, Nicholas C Henderson, Ravi Varadhan
Mechanisms of Ageing and Development
|
October 28, 2008
Opinion section on frailty
Linda P Fried, Ravi Varadhan, Vilhelm A Bohr
Lifetime Data Analysis
|
April 15, 2014
Semicompeting risks in aging research: methods, issues and needs
Ravi Varadhan, Qian-Li Xue, Karen Bandeen-Roche
Age and Ageing
|
January 15, 2016
Race and fall risk: data from the National Health and Aging Trends Study (NHATS)
Daniel Q Sun, Jin Huang, Ravi Varadhan, et al.
Journal of the American Medical Directors Association
|
June 19, 2021
Geographic Regions Enriched with Frail Older Adults
Jodi B Segal, Jin Huang, Jiafeng Zhu, et al.
American Journal of Epidemiology
|
September 24, 2017
External validation of the claims-based frailty index in the national health and aging trends study cohort
Jodi B Segal, Jin Huang, David L Roth, et al.
Page
of 18